Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Platelet antiaggregants].

L Verstraeten1, P François

  • 1Service de Biochimie médicale Cliniques Universitaires St-Luc, Bruxelles, Belgique.

Journal De Pharmacie De Belgique
|July 1, 1991
PubMed
Summary

Acetylsalicylic acid is a highly effective antiplatelet agent for preventing thromboses, particularly those linked to atherosclerosis. Current evidence suggests combination therapies do not offer superior benefits over aspirin alone.

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Surgical management of acquired rectourethral fistula: a retrospective analysis of 52 consecutive patients.

Techniques in coloproctology·2020
Same author

Evaluation of a real-time multiplex PCR for the simultaneous detection of Campylobacter jejuni, Salmonella spp., Shigella spp./EIEC, and Yersinia enterocolitica in fecal samples.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·2014
Same author

[Quality control of equipment used for radiotherapy].

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique·2003
Same author

[Analysis of the medico-economic literature comparing primary angioplasty and thrombolysis in the management of acute myocardial infarction].

Annales de cardiologie et d'angeiologie·2003
Same author

[Mediastinal form of cat-scratch disease].

Archives de l'Institut Pasteur de Madagascar·2002
Same author

[The process of evaluation and improvement of medical practice in Quebec].

Presse medicale (Paris, France : 1983)·2002

Area of Science:

  • Cardiovascular Medicine
  • Pharmacology

Context:

  • Atherosclerosis is a leading cause of thrombotic events.
  • Antiplatelet therapy is crucial for secondary prevention.

Purpose:

  • To review the efficacy and usage of antiplatelet agents.
  • To compare combination therapies with monotherapy.

Summary:

  • Acetylsalicylic acid (aspirin) is the primary antiplatelet agent, with a recommended dose of 300 mg daily.
  • Ticlopidine and dipyridamole are alternatives but have more contraindications.
  • Clinical studies indicate no added benefit of combining antiplatelet agents over aspirin monotherapy.

Impact:

  • Provides guidance on optimal antiplatelet selection and dosage.
  • Highlights limitations and contraindications of certain agents.
  • Supports the continued use of aspirin as a cornerstone therapy.